Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Sep;50(3):126-8.
doi: 10.5045/br.2015.50.3.126. Epub 2015 Sep 22.

Cellular Immunotherapy as a Beacon of Hope for Hematological Malignancies

Affiliations
Free PMC article
Review

Cellular Immunotherapy as a Beacon of Hope for Hematological Malignancies

Hyun-Ju Lee et al. Blood Res. .
Free PMC article

Conflict of interest statement

Authors' Disclosures of Potential Conflicts of Interest: No potential conflicts of interest relevant to this article were reported.

Similar articles

See all similar articles

References

    1. Bachireddy P, Burkhardt UE, Rajasagi M, Wu CJ. Haematological malignancies: at the forefront of immunotherapeutic innovation. Nat Rev Cancer. 2015;15:201–215. - PMC - PubMed
    1. Hoang MD, Jung SH, Lee HJ, et al. Dendritic cell-based cancer immunotherapy against multiple myeloma: from bench to clinic. Chonnam Med J. 2015;51:1–7. - PMC - PubMed
    1. Nguyen-Pham TN, Lee YK, Lee HJ, et al. Cellular immunotherapy using dendritic cells against multiple myeloma. Korean J Hematol. 2012;47:17–27. - PMC - PubMed
    1. Lee JJ, Kook H, Park MS, et al. Immunotherapy using autologous monocyte-derived dendritic cells pulsed with leukemic cell lysates for acute myeloid leukemia relapse after autologous peripheral blood stem cell transplantation. J Clin Apher. 2004;19:66–70. - PubMed
    1. Nguyen-Pham TN, Jung SH, Vo MC, et al. Lenalidomide synergistically enhances the effect of dendritic cell vaccination in a model of murine multiple myeloma. J Immunother. 2015;38:330–339. - PubMed
Feedback